Continuum Health Ventures

Continuum Health Ventures (CHV) is an early-stage venture capital fund that seeds, nurtures, and accelerates the next generation of Healthtech, Techbio, and Healthspan Extension (Longevity) startups that will focus on disrupting sickcare. The 'Continuum' Approach Thesis Prevention and Aging Biology: We are a thesis-driven organization focused on the convergence of health and technology within the Fifth Industrial Revolution. We believe we are in the early innings of digitizing healthcare, and our mission is to leverage precision and personalized interventions to identify disease before it's a material issue. We also are focused on stagnating and/or reversing some of the disease hallmarks associated with aging. Identify Partnering for the Future: We are on a journey to identify the next generation of founders and startups poised to define the future of medicine. As former doctors, scientists, technologists, and founders ourselves, we understand the road ahead and immerse ourselves deeply with the teams we back. Our goal is to be active, early investors—committed partners who remain by your side all the way to the finish line. Catalyze Driving Growth Beyond Capital: We provide the essential capital, active operational support, and unparalleled market access your venture needs. While our primary focus is the US, our reach extends globally to Canada, the EU, the Middle East, India, Japan, Korea, Singapore, and beyond. We combine strategic thinking with a powerful network across payors, providers, pharma, device, and consumer tech to ensure your commercialization is expedited and highly effective.